What is the Projected CAGR value of the Nuclear Medicine Radioisotopes Market?
Nuclear Medicine Radioisotopes Market is expected to grow at a CAGR of 12.8% during the forecasting period 2023-2030.
Who are the key players in Nuclear Medicine Radioisotopes Market?
Key players are NTP Radioisotopes SOC Ltd, Nordion Inc., (Sotera Health company), Cardinal Health, Inc, Bayer AG, GE Company (GE Healthcare) and NorthStar Medical Radioisotopes, LLC.
Which is the fastest growing region in the Nuclear Medicine Radioisotopes Market?
Asia Pacific is the fastest growing market share during the forecast period.
Which is the Largest Market Share in the Nuclear Medicine Radioisotopes Market?
North America is the Largest Market Share in Nuclear Medicine Radioisotopes Market.